Patent Cases Denied by Supreme Court March 9th

|

Information via email from BNA's United States Patents Quarterly® Highlights  for  Vol. 89, Number 11, March 16, 2009.   Highlights are published weekly,

The U.S. Supreme Court denied review in the following patent cases on March 9:

Apotex Corp. v. Astrazeneca AB (No. 08--867). The U.S. Court of Appeals for the Federal Circuit held (87 USPQ2d 1865) that accused pharmaceutical formulation infringes patents for inert subcoating that increases storage stability and provides sufficient gastric acid resistance to prevent active ingredient in drug designed to treat acid-related gastrointestinal disorders from degrading in stomach.

Muniauction Inc. v. Thomson Corp. (No. 08-847). The Federal Circuit held (87 USPQ2d 1350) that competitor did not infringe certain claims asserted by holder of patent directed to electronic methods for conducting original-issuer municipal bond auctions over electronic network, using Web browser.

R.J. Reynolds Tobacco Co. v. Star Scientific Inc. (No. 08-918). The Federal Circuit held (88 USPQ2d 1001) that district court clearly erred in finding that patents on tobacco curing process, aimed at lowering levels of carcinogens in cured tobacco, were unenforceable for inequitable conduct.

You can receive BNA Highlights of the USPQ via email  from BNA .  Simply go to BNA's main page and scroll down to the bottom.  On the right-hand side you will find a box like the one below with the link to "sign up for or modify e-mail preferences."


BNA_Sign-up.png


http://0-news.bna.com.cardcatalog.piercelaw.edu/ptln/


About this Entry

This page contains a single entry by Roberta Woods published on March 20, 2009 8:00 AM.

LexisNexis and March Madness was the previous entry in this blog.

Constitutional Amendments : 1789 to the Present is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.